| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world
|
Nishida, Toshirou
|
|
|
23 |
1 |
p. 118-125
|
artikel
|
| 2 |
A genetic origin for acid–base imbalance triggers the mitochondrial damage that explains the autoimmune response and drives to gastric neuroendocrine tumours
|
Benítez, Javier
|
|
|
23 |
1 |
p. 52-63
|
artikel
|
| 3 |
A genetic origin for acid–base imbalance triggers the mitochondrial damage that explains the autoimmune response and drives to gastric neuroendocrine tumours
|
Benítez, Javier
|
|
|
23 |
1 |
p. 52-63
|
artikel
|
| 4 |
A message from the new editor-in-chief
|
Kodera, Yasuhiro
|
|
|
23 |
1 |
p. 1-2
|
artikel
|
| 5 |
Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT
|
Nishimura, Takashi
|
|
|
23 |
1 |
p. 82-94
|
artikel
|
| 6 |
Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT
|
Nishimura, Takashi
|
|
|
23 |
1 |
p. 82-94
|
artikel
|
| 7 |
Clinical outcomes of non-exposed endoscopic wall-inversion surgery for gastric submucosal tumors: long-term follow-up and functional results
|
Aoyama, Junya
|
|
|
23 |
1 |
p. 154-159
|
artikel
|
| 8 |
Clinical outcomes of non-exposed endoscopic wall-inversion surgery for gastric submucosal tumors: long-term follow-up and functional results
|
Aoyama, Junya
|
|
|
23 |
1 |
p. 154-159
|
artikel
|
| 9 |
Convolutional neural network for the diagnosis of early gastric cancer based on magnifying narrow band imaging
|
Li, Lan
|
|
|
23 |
1 |
p. 126-132
|
artikel
|
| 10 |
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer
|
Chau, Ian
|
|
|
23 |
1 |
p. 142
|
artikel
|
| 11 |
Correction to: Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways
|
Moro, Hiroshi
|
|
|
23 |
1 |
p. 116-117
|
artikel
|
| 12 |
Correction to: Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways
|
Moro, Hiroshi
|
|
|
23 |
1 |
p. 116-117
|
artikel
|
| 13 |
Correction to: Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E = G and GE cancers
|
Hölscher, Arnulf H.
|
|
|
23 |
1 |
p. 10
|
artikel
|
| 14 |
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer
|
Chau, Ian
|
|
|
23 |
1 |
p. 133-141
|
artikel
|
| 15 |
Different risks of nodal metastasis by tumor location in remnant gastric cancer after curative gastrectomy for gastric cancer
|
Takahashi, Kazuya
|
|
|
23 |
1 |
p. 195-201
|
artikel
|
| 16 |
Different risks of nodal metastasis by tumor location in remnant gastric cancer after curative gastrectomy for gastric cancer
|
Takahashi, Kazuya
|
|
|
23 |
1 |
p. 195-201
|
artikel
|
| 17 |
Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways
|
Moro, Hiroshi
|
|
|
23 |
1 |
p. 105-115
|
artikel
|
| 18 |
Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways
|
Moro, Hiroshi
|
|
|
23 |
1 |
p. 105-115
|
artikel
|
| 19 |
Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers
|
Hölscher, Arnulf H.
|
|
|
23 |
1 |
p. 3-9
|
artikel
|
| 20 |
Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers
|
Hölscher, Arnulf H.
|
|
|
23 |
1 |
p. 3-9
|
artikel
|
| 21 |
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer
|
Satoh, Taroh
|
|
|
23 |
1 |
p. 143-153
|
artikel
|
| 22 |
Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607)
|
Yano, Tomonori
|
|
|
23 |
1 |
p. 168-174
|
artikel
|
| 23 |
Factors associated with technical difficulty of endoscopic submucosal dissection for early gastric cancer that met the expanded indication criteria: post hoc analysis of a multi-institutional prospective confirmatory trial (JCOG0607)
|
Yano, Tomonori
|
|
|
23 |
1 |
p. 168-174
|
artikel
|
| 24 |
Hedgehog signalling pathway activation in gastrointestinal stromal tumours is mediated by primary cilia
|
Iruzubieta, Pablo
|
|
|
23 |
1 |
p. 64-72
|
artikel
|
| 25 |
Hedgehog signalling pathway activation in gastrointestinal stromal tumours is mediated by primary cilia
|
Iruzubieta, Pablo
|
|
|
23 |
1 |
p. 64-72
|
artikel
|
| 26 |
IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2
|
Huang, Ju
|
|
|
23 |
1 |
p. 23-38
|
artikel
|
| 27 |
IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2
|
Huang, Ju
|
|
|
23 |
1 |
p. 23-38
|
artikel
|
| 28 |
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance
|
Pernot, Simon
|
|
|
23 |
1 |
p. 73-81
|
artikel
|
| 29 |
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance
|
Pernot, Simon
|
|
|
23 |
1 |
p. 73-81
|
artikel
|
| 30 |
Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance
|
Chen, Qi-Yue
|
|
|
23 |
1 |
p. 184-194
|
artikel
|
| 31 |
Laparoscopic total gastrectomy for upper-middle advanced gastric cancer: analysis based on lymph node noncompliance
|
Chen, Qi-Yue
|
|
|
23 |
1 |
p. 184-194
|
artikel
|
| 32 |
Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer
|
Nishikawa, Kazuhiro
|
|
|
23 |
1 |
p. 160-167
|
artikel
|
| 33 |
Meta-analysis of two randomized phase III trials (TCOG GI-0801 and ECRIN TRICS) of biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer
|
Nishikawa, Kazuhiro
|
|
|
23 |
1 |
p. 160-167
|
artikel
|
| 34 |
Peritoneal metastasis in gastric cancer: results from the German database
|
Rau, Beate
|
|
|
23 |
1 |
p. 11-22
|
artikel
|
| 35 |
Peritoneal metastasis in gastric cancer: results from the German database
|
Rau, Beate
|
|
|
23 |
1 |
p. 11-22
|
artikel
|
| 36 |
Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer
|
Yamashita, Kohei
|
|
|
23 |
1 |
p. 95-104
|
artikel
|
| 37 |
Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer
|
Yamashita, Kohei
|
|
|
23 |
1 |
p. 95-104
|
artikel
|
| 38 |
Survival after neoadjuvant approaches to gastroesophageal junction cancer
|
Xiang, Michael
|
|
|
23 |
1 |
p. 175-183
|
artikel
|
| 39 |
Survival after neoadjuvant approaches to gastroesophageal junction cancer
|
Xiang, Michael
|
|
|
23 |
1 |
p. 175-183
|
artikel
|
| 40 |
Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors
|
Liu, Weizhen
|
|
|
23 |
1 |
p. 39-51
|
artikel
|
| 41 |
Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors
|
Liu, Weizhen
|
|
|
23 |
1 |
p. 39-51
|
artikel
|
Tijdschrift beschrijving